Gagnon Securities’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-2,114
Closed -$289K – 99
2017
Q3
$289K Sell
2,114
-78
-4% -$11.8K 0.11% 72
2017
Q2
$385K Sell
2,192
-6,675
-75% -$949K 0.11% 59
2017
Q1
$1.06M Buy
8,867
+149
+2% +$15.5K 0.46% 40
2016
Q4
$850K Sell
8,718
-8
-0.1% -$733 0.36% 47
2016
Q3
$819K Sell
8,726
-39
-0.4% -$3.91K 0.35% 48
2016
Q2
$944K Hold
8,765
– – 0.44% 40
2016
Q1
$1.05M Buy
8,765
+1,528
+21% +$160K 0.5% 37
2015
Q4
$862K Buy
7,237
+1,186
+20% +$153K 0.39% 42
2015
Q3
$1.03M Sell
6,051
-1,363
-18% -$261K 0.5% 34
2015
Q2
$1.44M Sell
7,414
-36,816
-83% -$6.83M 0.57% 29
2015
Q1
$6.55M Sell
44,230
-17,137
-28% -$2.61M 2.17% 16
2014
Q4
$9.57M Sell
61,367
-3,417
-5% -$492K 3.07% 14
2014
Q3
$9.29M Sell
64,784
-965
-1% -$140K 3.1% 14
2014
Q2
$8.58M Sell
65,749
-2
-0% -$254 2.78% 15
2014
Q1
$8.05M Buy
65,751
+645
+1% +$69.9K 2.39% 17
2013
Q4
$6.91M Buy
65,106
+1,885
+3% +$183K 2.08% 20
2013
Q3
$7.09M Sell
63,221
-2,436
-4% -$276K 2.21% 19
2013
Q2
$7.41M Buy
+65,657
New +$8.03M 2.68% 18

Other funds holding SRGA

Gagnon Securities's SRGA Position: Q4 2017 in Review

Gagnon Securities sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2017, closing a stake of 2,114 shares — an estimated $289K sold.

Gagnon Securities first reported a position in SRGA in Q2 2013 and held it in 18 quarters. The position peaked at $9.57M in Q4 2014. 109 funds tracked by Wall St. Rank hold SRGA as of Q4 2017.

  • Gagnon Securities reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Gagnon Securities sold 2,114 Surgalign Holdings, Inc. Common Stock shares in Q4 2017, an estimated $289K.
  • Gagnon Securities first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Gagnon Securities's Surgalign Holdings, Inc. Common Stock position peaked at $9.57M in Q4 2014.
  • 109 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2017.

Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.